Randomized trial · people

Ipamorelin did not speed first meal after bowel surgery vs placebo

Checked against the paper Randomized trialPublished by PepVault

The takeaway

In this small trial, ipamorelin given into a vein after bowel surgery was well tolerated but did not significantly speed the return of normal eating compared with placebo.

Kind
Randomized trial
Studied in
People
Published
2014
Journal
Int J Colorectal Dis

What they tested

The team tested whether ipamorelin, a drug that switches on the ghrelin receptor, is safe and helps with postoperative ileus (when the bowel is slow to start working again after surgery) in people who had bowel resection.

How the study was done

A phase 2, multicenter, double-blind, placebo-controlled randomized trial in hospital patients after open or laparoscopic small or large bowel resection, with 114 patients in the safety and main efficacy analyses. Patients got 0.03 mg/kg ipamorelin or placebo (a dummy infusion) into a vein twice daily from day 1 after surgery until day 7 or discharge.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking ipamorelin? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

The median time from first dose to tolerating a standard solid meal was 25.3 h with ipamorelin and 32.6 h with placebo, a gap that was not statistically significant (p = 0.15). Adverse events that began during treatment showed up in 87.5% of the ipamorelin group and 94.8% of the placebo group. The authors judged ipamorelin well tolerated and found no significant differences from placebo in the key or secondary efficacy measures.

What it doesn’t show

This was a small, early proof-of-concept trial, and it enrolled patients with a wide range of underlying conditions. It only tested one dose given into a vein for up to 7 days in hospital after bowel surgery.

The paper

Beck et al. Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients. Int J Colorectal Dis. 2014.

The compound

More studies on Ipamorelin

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking ipamorelin? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo